Cognitive performance effects of subcutaneous nicotine in smokers and never-smokers

Psychopharmacology

Volumn 127, Issue 1, 1996, Pages 31-38

  Foulds, Jonathan ^a,b   Stapleton, John ^a   Swettenham, John ^a   Bell, Nicholas ^a   McSorley, Kevin ^a   Russell, Michael A H ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cognitive performance; Nicotine; Nonsmoker; Smoker; Subcutaneous

Indexed keywords

NICOTINE; PLACEBO;

ABSTINENCE; ADULT; ARTICLE; CIGARETTE SMOKING; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL FLICKER FUSION; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HUMAN EXPERIMENT; INFORMATION PROCESSING; LOGIC; MALE; MEMORY; MENTAL PERFORMANCE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; VISUAL INFORMATION; WORD RECOGNITION;

EID: 0029820029     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02805972     Document Type: Article

References (32)

1. Clark WC, Rutschman J, Link R, Brown JA (1963) Comparison of flicker fusion thresholds obtained by the methods of forced choice and limits in psychiatric patients. Percept Mot Skills 16: 19-30
2. Cohen C, Pickworth WB, Bunker EB, Henningfield JE (1994) Caffeine antagonises EEG effects of tobacco withdrawal. Pharmacol Biochem Behav 47:919-926
3. Curran HV, Sakulsriprong M, Lader M (1988) Antidepressants and human memory: an investigation of four drugs with different sedative and anticholinergic profiles. Psychopharmacology 95: 520-527
4. Foulds J, McSorley K, Sneddon J, Feyerabend C, Jarvis MJ, Russell MAH (1994) Effect of subcutaneous nicotine injections on EEG alpha frequency in non-smokers: a placebo-controlled pilot study. Psychopharmacology 115:163-166
5. Freeman PR (1989) The performance of the two-stage analysis of two-treatment, two-period crossover trials. Statist Med 8: 1421-1432
6. Heishman SJ, Taylor RC, Henningfield JE (1994) Nicotine and smoking: a review of effects on human performance. Exp Clin Psychopharmacology 2:345-395
7. Henningfield JE, Stapleton JM, Benowitz NL, Grayson RF, London ED (1993) Higher levels in arterial than venous blood after cigarette smoking. Drug Alcohol Depend 33:23-29
8. Hughes JR (1991) Distinguishing withdrawal relief and direct effects of smoking. Psychopharmacology 104:409-410
9. Jarvis MJ (1993) Does caffeine intake enhance absolute levels of cognitive performance? Psychopharmacology 110:45-52
10. Jones GM, Sahakian BJ, Levy R, Warburton DM, Gray JA (1992) Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer s disease. Psychopharmacology 108:485-494
11. Kerr JS, Sherwood N, Hindmarch I (1991) Separate and combined effects of social drugs on psychomotor performance. Psychopharmacology 104: 113-119
12. Le Houezec J, Jacob P, Benowitz NL (1993) A clinical pharmacological study of subcutaneous nicotine. Eur J Clin Pharmacol 44:225-230
13. Le Houezec J, Halliday R, Benowitz NL, Callawav E, Naylor H, Herzig K (1994) A low dose of subcutaneous nicotine improves information processing in non-smokers. Psychopharmacology 114:628-634
14. Mangan GL, Golding J (1978) An "enhancement" model of smoking maintenance? In: Thornton RE (ed) Smoking behaviour: physiological and psychological influences. Churchill Livingston, Edinburgh, pp 87-114
15. Perkins KA, Epstein LH, Stiller RL, Sexton JE, Debski TD, Jacob RG (1990) Behavioral performance effects of nicotine in smokers and non-smokers. Pharmacol Biochem Behav 37:11-15
16. Perkins KA, Grobe JE, Fonte C, Goettler J, Caggiula AR, Reynolds WA, Stiller RL, Scierka A, Jacob RG (1994) Chronic and acute tolerance to subjective, behavioral and cardiovascular effects of nicotine in humans. J Pharmacol Exp Ther 270:628-638
17. Pritchard WS, Robinson JH, Guy TD (1992) Enhancement of continuous performance task reaction time by smoking in non-deprived smokers. Psychopharmacology 108:437-442
18. Provost SC, Woodward R (1991) Effects of nicotine gum on repeated administration of the stroop test. Psychopharmacology 104:536-540
19. Russell MAH, Jarvis MJ, Jones G, Feyerabend C (1990) Non-smokers show acute tolerance to subcutaneous nicotine. Psychopharmacology 102:56-58
20. Sahgal A (1987) Some limitations of indices derived from signal detection theory, evaluation of an alternative index for measuring bias in memory tasks. Psychopharmacology 91:517-520
21. Senn SJ (1992) Is the "simple carry-over" model useful? Statist Med 11:715-726
22. Snyder FR, Henningfield JE (1989) Effects of nicotine administration following 12 h of tobacco deprivation: assessment on computerised performance tasks. Psychopharmacology 97:17-22
23. Snyder FR, Davis FC, Henningfield JE (1989) The tobacco withdrawal syndrome: performance decrements assessed on a computerized test battery. Drug Alcohol Depend 23: 259-266
24. Sutherland G, Russell MAH, Stapleton J, Feyerabend C, Ferno O (1992) Nasal nicotine spray: a rapid nicotine delivery system. Psychopharmacology 108:512-518
25. Waller D, Levander S (1980) Smoking and vigilance: the effects of tobacco smoking on CFF as related to personality and smoking habits. Psychopharmacology 70:131-136
26. Warburton DM (1992) Nicotine as a cognitive enhancer. Prog Neuropsychopharmacol Biol Psychiatry 16:181-191
27. Warburton DM, Arnall C (1994) Improvements in performance without nicotine withdrawal. Psychopharmacology 115:539-542
28. Wesnes K, Warburton D (1983) Smoking, nicotine and human performance. Pharmacol Ther 21:189-208
29. Wesnes K, Warburton DM (1984a) The effects of cigarettes of varying yield on rapid information processing performance. Psychopharmacology 82:338-342
30. Wesnes K, Warburton DM (1984b) Effects of scopolamine and nicotine on human rapid information processing performance. Psychopharmacology 82:147-150
31. West RJ, Hack S (1991) Effects of cigarettes on memory search and subjective ratings. Pharmacol Biochem Bchav 38:281-286
32. West RJ, Jarvis MJ (1986) Effects of nicotine on finger tapping rate in non-smokers. Pharmacol Biochem Behav 25:727-731